These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27717035)

  • 1. Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome.
    Kaffenberger TM; Mandal R; Schaitkin BM; Hirsch BE
    Laryngoscope; 2017 May; 127(5):1199-1201. PubMed ID: 27717035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature.
    Penney SE; Bruce IA; Saeed SR
    J Neurol; 2006 Jul; 253(7):857-60. PubMed ID: 16845571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injection for objective tinnitus from palatal myoclonus: a case report.
    Srirompotong S; Tiamkao S; Jitpimolmard S
    J Med Assoc Thai; 2002 Mar; 85(3):392-5. PubMed ID: 12117033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.
    McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective tinnitus from palatal myoclonus. Use of botulinum toxin: a case report.
    Conill Tobías N; de Paula Vernetta C; García Callejo FJ; Marco Algarra J
    Acta Otorrinolaringol Esp; 2012; 63(5):391-2. PubMed ID: 21513907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palatal myoclonus: algorithm for management with botulinum toxin based on clinical disease characteristics.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2014 May; 124(5):1164-9. PubMed ID: 24668771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Middle ear myoclonus associated with forced eyelid closure in children: diagnosis and treatment outcome.
    Lee GH; Bae SC; Jin SG; Park KH; Yeo SW; Park SN
    Laryngoscope; 2012 Sep; 122(9):2071-5. PubMed ID: 22778030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of a postpolio tinnitus with type a botulinum toxin.
    Scolozzi P; Carrera E; Jaques B; Kuntzer T
    Laryngoscope; 2005 Jul; 115(7):1288-90. PubMed ID: 15995523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botox transient treatment of tinnitus due to stapedius myoclonus: case report.
    Liu HB; Fan JP; Lin SZ; Zhao SW; Lin Z
    Clin Neurol Neurosurg; 2011 Jan; 113(1):57-8. PubMed ID: 20800344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral muscular tinnitus due to myoclonus of extrinsic auricular muscles.
    Lee K; Chang J; Park S; Im GJ; Choi HJ; Kim JH; Kim HJ
    Auris Nasus Larynx; 2015 Apr; 42(2):173-5. PubMed ID: 25466808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.
    Frei K; Truong DD; Dressler D
    Eur J Neurol; 2006 Feb; 13 Suppl 1():30-5. PubMed ID: 16417595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin for the treatment of somatic tinnitus.
    Láinez MJ; Piera A
    Prog Brain Res; 2007; 166():335-8. PubMed ID: 17956797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral Therapy for Muscular Objective Tinnitus in Forceful Eyelid Closure Syndrome (FECS): A Case Report.
    Maeyama N; Kamakura T; Nishimura M; Kawashima K; Masumura C; Yasui T
    J Int Adv Otol; 2021 May; 17(3):278-280. PubMed ID: 34100757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of objective tinnitus with transpalatal Botox
    Dang J; Carol Liu YC
    Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():22-24. PubMed ID: 30554701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with botulinum toxin improves the hyperexcitability of the facial motoneuron in patients with hemifacial spasm.
    Ishikawa M; Takashima K; Kamochi H; Kusaka G; Shinoda S; Watanabe E
    Neurol Res; 2010 Jul; 32(6):656-60. PubMed ID: 19660185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMG-guided salpingopharyngeus Botox injection for palatal myoclonus.
    Wan TK; Chen JT; Wang PC
    B-ENT; 2013; 9(1):67-9. PubMed ID: 23641594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Festoon formation after infraorbital botulinum A toxin: a case report.
    Goldman MP
    Dermatol Surg; 2003 May; 29(5):560-1; discussion 561. PubMed ID: 12752529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type a for dysthyroid upper eyelid retraction.
    Morgenstern KE; Evanchan J; Foster JA; Cahill KV; Burns JA; Holck DE; Perry JD; Wulc AE
    Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):181-5. PubMed ID: 15167723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of botulinum toxin A in treatment of tinnitus.
    Stidham KR; Solomon PH; Roberson JB
    Otolaryngol Head Neck Surg; 2005 Jun; 132(6):883-9. PubMed ID: 15944559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.